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Ginseng Total Saponin Improves Podocyte Hyperpermeability 
Induced by High Glucose and Advanced Glycosylation 
Endproducts
Early diabetic nephropathy is characterized by glomerular hyperpermeability as a result of 
impaired glomerular filtration structure caused by hyperglycemia, glycated proteins or 
irreversible advanced glycosylation endproducts (AGE). To investigate the effect of ginseng 
total saponin (GTS) on the pathologic changes of podocyte ZO (zonula occludens)-1 protein 
and podocyte permeability induced by diabetic conditions, we cultured mouse podocytes 
under: 1) normal glucose (5 mM, = control); 2) high glucose (HG, 30 mM); 3) AGE-added; 
or 4) HG plus AGE-added conditions and treated with GTS. HG and AGE increased the 
dextran filtration of monolayered podocytes at early stage (2-8 hr) in permeability assay. In 
confocal imaging, ZO-1 colocalized with actin filaments and β-catenin at cell contact 
areas, forming intercellular filtration gaps. However, these diabetic conditions suppressed 
ZO-1 immunostainings and disrupted the linearity of ZO-1. In Western blotting, diabetic 
conditions also decreased cellular ZO-1 protein levels at 6 hr and 24 hr. GTS improved such 
quantitative and qualitative changes. These findings imply that HG and AGE have an 
influence on the redistribution and amount of ZO-1 protein of podocytes thereby causing 
hyperpermeability at early stage, which can be reversed by GTS. 
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INTRODUCTION
Diabetic nephropathy is the leading cause of end-stage renal 
disease (ESRD) requiring dialysis or renal transplantation, how-
ever, the predisposing factors and pathogenic mechanisms of 
diabetic nephropathy have remained unclear (1, 2). Early clini-
cal manifestations of diabetic nephropathy result from hyperfil-
tration and microalbuminuria, and progress to overt proteinuria 
and progressive renal injury. Simultaneous morphological chang-
es in glomeruli include glomerular hypertrophy, increase in me-
sangial matrix, thickening of glomerular basement membrane 
(GBM), and effacement, denudation, and loss of podocytes (1, 
2). Accompanying biochemical alterations with pathological 
changes lead to increase in glomerular permeability as a result 
of impaired glomerular filtration structures. These changes are 
caused by hyperglycemia, secondary glycated proteins or irre-
versible advanced glycosylation endproducts (AGE) (3, 4).
  As the glomerular capillary wall functions as an efficient and 
selective barrier that allows a high flow rate of filtration for plas-
ma water and small solutes, glomerular capillary wall should 
have strong but selectively permeable cell-to-cell junction. There-
fore, the glomerular slit diaphragm (SD), a main barrier compo-
nent in glomerular filtration, serves as a selective barrier and is 
connected to intracellular adapter proteins including ZO (zonu-
la occludens)-1 (5-7). ZO-1 is a peripheral membrane protein 
associated with the cytoplasmic surface of the tight junction or 
ZO in all epithelial and endothelial cell types studied (8). It is 
also expressed on the cytoplasmic surface of podocyte foot pro-
cesses at the point of insertion of the SD and linked to the actin 
cytoskeleton on the other side (5-7). Therefore, ZO-1 protein as 
a component of the SD plays a pivotal role in maintaining the 
glomerular permeability by connecting SD structure and actin 
cytoskeleton. 
  The root of Panax ginseng has been widely used for cancer, 
diabetes, and cardiovascular diseases for thousands of years in 
oriental countries including Korea (9, 10). Several investigations 
strongly support the evidence that ginseng root possesses anti-
diabetic properties, such as inhibition of intestinal glucose ab-
sorption, increase in energy expenditure, improving sensitivity 
to insulin and stimulation of sugar metabolism, etc. (11-13). 
Moreover, ginseng root and its derivatives have been beneficial 
in both type 2 diabetic patients and healthy individuals (14-16) Ha T-S, et al.  •  Ginseng Saponin Improves Diabetic Podocyte Hyperpermeability 
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as well as type 1 and 2 animal diabetic models (10-13, 17, 18). 
  Ginseng has also been reported to be effective in prevention 
and treatment of diabetic nephropathy of type 1 and type 2 dia-
betic animal models as followings. In type 1 insulin-dependent 
diabetic nephropathy animal models induced by streptozoto-
cin (STZ), sun ginseng (19), heat-processed American ginseng 
(20), and 20(S)-ginsenoside Rg3 (21) ameliorated elevated se-
rum glucose and renal damage. In type 2 insulin-independent 
diabetic nephropathy animal models, 20(S)-ginsenoside Rg3 
also decreased the elevated blood glucose and proteinuria and 
augmented creatinine clearance in type 2 diabetic Otsuka Long-
Evans Tokushima Fatty (OLETF) (22). Although the renal protec-
tive effect of ginseng components in diabetic models has been 
reported, there were very few reports which have attempted to 
elucidate the changes of glomerular filtration structures. In this 
study, we investigated the effect of ginseng saponin on the patho-
logic changes of podocyte ZO-1 protein and podocyte permea-
bility induced by diabetic conditions.
MATERIALS AND METHODS
Cell culture of mouse podocytes
Conditionally immortalized mouse podocytes were kindly pro-
vided by Dr. Peter Mundel (University of Harvard, Boston, MA, 
USA) and were cultured and differentiated as described previ-
ously (23). Briefly, to stimulate podocytes proliferation, cells were 
cultivated at 33°C (permissive conditions) in a culture medium 
supplemented with 10 U/mL mouse recombinant γ-interferon 
(Roche, Mannheim, Germany) to induce expression of temper-
ature-sensitive large T antigen. To induce differentiation, podo-
cytes were maintained at 37°C without γ-interferon (non-per-
missive conditions) for at least 2 weeks.
Culture additives
Cells were serum-deprived to reduce background 24 hr before 
each experiment, then exposed to glucose and/or AGE. Mouse 
podocytes were incubated in culture media containing either 5 
mM (normal glucose, NG) or 30 mM glucose (HG) without in-
sulin. AGE was produced by the technique previously described 
by Ha et al. (24). To imitate the long-term diabetic condition, 
AGE was added (5 μg/mL) and controls were established using 
unmodified bovine serum albumin (BSA, 5 μg/mL). To exclude 
the effect of additionally produced glycated proteins in culture 
conditions, no longer than 48 hr of incubation was used. Fetal 
bovine serum was reduced to 0.5% on the last media change to 
reduce background before protein and RNA extraction. For iden-
tification purposes, AGE or BSA was denoted as ‘A’ or ‘B’, and 
glucose at 5 or 30 mM by ‘5’ or ‘30’, respectively. Their meanings 
of each condition have been described before (24). 
  For ginseng treatment podocytes were incubated with gin-
seng total saponin (GTS) at the concentrations of 0, 0.2, 1, 5, 25 
μg/mL for 6, 24, 48 hr. GTS was kindly provided by Korea Gin-
seng Corporation.
Monolayer permeability assay
Podocytes were seeded and grown confluently in monolayer 
pattern on the surface of cellulose semi-permeable membranes 
(Millicell-HA, Millipore Corp., Bedford, MA, USA) having 0.45 
μm of pore size. After differentiation and complete washings of 
previously described media, fresh maintenance media without 
AGE and BSA were replaced into each aspect. Hydrostatic pres-
sure was applied continuously from (lower) to apical to basolat-
eral aspect. Then, 1 mg/mL of FITC-tagged anionic dextran (Mo-
lecular Probes, Invitrogen, Eugene, OR, USA) were put into the 
apical media and the filtered amounts of dextran at each incu-
bation time were determined by spectrophotometer at 492 nm.  
Confocal image analysis 
Podocytes that were grown on type I collagen-coated glass cov-
er slips incubated for 24 hr were fixed in 4% paraformaldehyde, 
permeabilized in phosphate buffer solution, blocked with 10% 
normal goat serum, and labeled with monoclonal rabbit anti-rat 
ZO-1 antibody (Invitrogen, Eugene, OR, USA) or TRITC-phal-
loidin (Sigma Chemical Co., St. Louis, MO, USA) for F-actin stain-
ing. Primary antibody-bound specimens were incubated with 
1:500 (v/v) Alexa 594 for red (Molecular Probes, Invitrogen)-con-
jugated respective secondary antibodies at RT for 1 hr. Cover-
slips were mounted in aqueous mountant and viewed with a 
Fluorescence microscope (BX51; OLYMPUS, Tokyo, Japan).
Western blotting 
The confluently grown cell layers incubated with additives dur-
ing 48-hr for ZO-1 and various durations for AGE were extracted 
and protein concentrations were determined as previously de-
scribed (24). For the Western blotting of ZO-1, 30 μg of boiled ex-
tracts was applied on 8% SDS-PAGE gels and transferred to poly-
vinylidene fluoride membranes (Bio-Rad Laboratories, Hercu-
les, CA, USA). Then, the membranes were air-dried and blocked 
in 3% fat-free milk before incubation with anti-ZO-1 antibody. 
After incubation with horseradish peroxidase-conjugated sec-
ondary antibodies (Santa Cruz Biotechnology Inc., Santa Cruz, 
CA, USA), bands were detected by using the ECL chemilumi-
nescence system (Amersham Biotech Ltd., Bucks, UK). Data on 
the densitometric analysis of ZO-1/β-tubulin ratio are expressed 
as mean ± SD. 
Statistical analysis
The results are presented as mean values ± standard deviation, 
as required under different conditions. The statistical significance 
was assessed by nonparametric Kruskal-Wallis ANOVA analy-
sis or Student t-test. P values less than 0.05 were considered sig-
nificant.Ha T-S, et al.  •  Ginseng Saponin Improves Diabetic Podocyte Hyperpermeability 
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RESULTS
Increased in vitro permeability by HG and AGE
At early stage (2-6 hr) of permeability assay, high glucose (B30) 
increased permeability, then, became to be a control level (B5) 
in Fig. 1A. On the other hand, AGE and high glucose (A30) in-
creased permeability at somewhat late stage (4-8 hr), then, be-
came to be a control level (B5) after 16 hr (Fig. 1B). Both hyper-
permeable changes induced by B30 and A30 g were improved 
by GTS (1 μg/mL). These results indicated that GTS improved 
podocyte hyperpermeability induced by either high glucose 
and/or AGE during hyperpermeable conditions.
Confocal image changes of ZO-1 
ZO-1 colocalized with actin filaments at cell contact areas (Fig. 
2A). GTS affected ZO-1 distribution to be concentrated at over 
5 μg/mL, therefore, we determined GTS concentration at 1 μg/
mL (Fig. 2A). ZO-1 also colocalized with β-catenin at cell contact 
areas and diabetic conditions including B30, A5, and especially 
A30 suppressed and disrupted the immunostaining and linear-
ity of ZO-1 protein (arrows, Fig. 2B) with β-catenin. GTS (1 μg/
mL) improved the decreased and separated ZO-1 immunostain-
ing to be as those in B5 (Fig. 2C). These findings imply that glu-
cose and AGE might have an influence on the redistribution and 
amount of ZO-1 protein of podocytes thereby causing hyperper-
meability, which could be reversed by GTS.
Western blotting of ZO-1 in cultured podocyte 
Density values for ZO-1 protein of representative immunoblots 
from each group revealed decreased cellular ZO-1 protein lev-
els in B30 and A30 conditions at 6 and 24 hr incubations (P <  
0.05) but not at 48 hr incubations compared with B5 (P > 0.05, 
Fig. 3A). High glucose (B30) suppressed ZO-1 protein amount 
by 16.0% at 6 hr, which was reversed by GTS and by 27.5% at 24 
hr incubation (Fig. 3A). Focusing on AGE and high glucose (A30) 
according to the incubation times, A30 condition decreased ZO-1 
Fig. 1. Effects of ginseng total saponin (GTS) on the increased monolayered podocyte permeability by diabetic conditions. High glucose (B30) increases permeability at early 
stage (A) and AGE and high glucose (A30) also increases permeability at mid stage (B). 
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Fig. 2. Distributional changes of ZO-1 by diabetic conditions and ginseng total sapo-
nin (GTS). ZO-1 colocalizes with actin filaments (A) and β-catenin (B) at cell contact 
areas. Diabetic conditions including B30, A5, and A30 suppresses and disrupts the 
immunostainings and linearity of ZO-1 protein (arrows, B and C), which improved by 
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protein amount by 21.7% at 6 hr and by 21.8% at 24 hr incuba-
tion (P < 0.05). GTS (1 μg/mL) improved the decreased ZO-1 
protein at both incubation times, especially at 6 hr significantly 
(Fig. 3B).
DISCUSSION
There have been several reports of Panax ginseng root (American 
and Asia ginseng) and its derivatives improving diabetic condi-
tions in both type 2 human diabetes as well as type 1 and 2 ani-
mal diabetic models (11-18). Ginseng has also been reported to 
be effective in diabetic nephropathy of type 1 and type 2 diabet-
ic animal models (19-22).
  There were various mechanisms explained as a mode of effec-
tive action by Panax ginseng root and its derivatives on diabetic 
nephropathy. In streptozotocin-induced model, Kang et al. (19, 
21) found that 20(S)-ginsenoside Rg3 and sun ginseng amelio-
rated elevated serum glucose, glycosylated protein, and thiobar-
bituric acid-reactive substance levels and, furthermore, sun gin-
seng decreased the levels of 3-nitrotyrosine, carboxymethylly-
sine, and receptors for AGE, which indicated that ginseng com-
ponents could prevent diabetic renal damage by attenuating the 
oxidative stress. Similarly, ginseng non-saponin (GNS) treatment 
increased Cu/Zn-SOD activity in this model (25). In type 2 insu-
lin-independent diabetic nephropathy animal models (OLETF), 
20(S)-ginsenoside Rg3 also decreased the elevated blood glu-
cose and proteinuria via inhibiting oxidative stress and advanced 
glycation endproduct formation (22).
  In cultured mesangial cells, one of the major pathologic glo-
merular cells in diabetic nephropathy, the total saponin and gin-
senoside-Rd fractions suppressed the proliferation of mesan-
gial cells (26) and ginsenoside Rb1 prevented the high glucose-
induced increase of fibronectin expression via the inhibition of 
MAPK-Akt signaling cascade (27). However, there were no re-
ports in this field using cultured podocytes, a major glomerular 
filtration component. 
  In type 1 insulin-dependent diabetic nephropathy animal 
models induced by streptozotocin (STZ), Kim and Chung (25) 
reported that GTS and GNS treatments slightly decreased blood 
pressure and ameliorated renal hypertrophy with the down-
regulations of TGF-β1 and fibronectin expressions and without 
affecting plasma glucose levels. Focusing on glomerular filtra-
tion structures, the main determinant of the development of hy-
perfiltration and proteinuria, Zhang et al. (28) found that ginsen-
oside Rgl improved the pathologic diabetic changes of glomer-
ular filtration, such as, GBM thickness and podocytopenia with 
the reduction of urine protein and serum creatine. As ginsen-
oside Rgl also improved the overexpressed levels of serum MCP-1 
and TNF-α, which correlated with the improved clinical and 
pathologic indices. In summary, the components of Panax gin-
seng root and its derivatives may play preventive or therapeutic 
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Fig. 3. Effects of diabetic conditions and ginseng total saponin (GTS) on the ZO-1 
protein assayed by Western blotting. The major band for ZO-1 protein at 205 kDa de-
creased in B30 and A30 conditions at 6 and 24 hr incubations, which improved by 
GTS (1 µg/mL) (A, B). Data on the densitometric analysis of ZO-1/β-tubulin (not 
shown) ratio are expressed as mean ± SD (n = 4). Control (100%); the value of B5. 
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roles in diabetic nephropathy via the modulation of oxidative 
stress, signaling pathways, cell cycling, and/or cytokines. How-
ever, we could not find any reports on the effects of ginseng on 
the podocyte molecules. 
  We previously reported that the increased albumin permea-
bility through podocytes monolayer by AGE and high glucose 
could be induced by a disruption of cell-to-cell size-selective SD 
barrier including ZO-1 (29), which supported by Rincon-Choles 
et al. (30). In this study, we found the positive effects of ginseng 
saponin on the pathologic changes of podocyte ZO-1 protein 
and podocyte hyperpermeability induced by diabetic conditions. 
Further studies on the connecting mechanisms, such as signal-
ing and oxidative stress, and the changes of other podocyte pro-
teins would be needed.
  In conclusion, the results of our in vitro study document that 
both high glucose- and AGE-added condition induce the distri-
butional change and suppress the production of ZO-1 protein, 
thus causing the phenotypical changes and hyperpermeability 
of podocytes, which can be improved by GTS. Therefore, GTS 
will be helpful to prevent the early hyperpermeable condition 
in diabetic nephropathy. 
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AUTHOR SUMMARY
Ginseng Total Saponin Improves Podocyte Hyperpermeability Induced by High 
Glucose and Advanced Glycosylation Endproducts
Tae-Sun Ha, Ji-Young Choi, Hye-Young Park and Jin-Seok Lee 
Early diabetic nephropathy is characterized by glomerular hyperpermeability as a result of podocyte injury. This study is to evaluate 
effects of ginseng total saponin (GTS) on the pathologic changes of podocyte ZO (zonula occludens)-1, a key molecule in podocyte 
permeability, induced by diabetic conditions. Diabetic conditions suppressed ZO-1 protein and mRNA expression and disrupted the 
linearity of ZO-1. GTS improved such quantitative and qualitative changes. These findings imply that diabetic conditions induce 
glomerular hyperpermeability by modulating podocytes ZO-1 and GTS can be a candidate for early renal protective agent in 
diabetes.